Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
European Journal of Immunology|July 1, 1987
Modulation of expression of class II histocompatibility antigens by secretion of a cellular inhibitor in K562 leukemic cellsP Krief, C Boucheix, C Billard, et al.
European Cytokine Network|January 1, 1996
Are interleukin-2 and interleukin-15 tumor promoting factors for human non-hematopoietic cells?B Azzarone, C Pottin-Clemenceau, P Krief, et al.
International Journal of Cancer|March 15, 1984
SV40 immortalization of adult human mesenchymal cells from neuroretina. Biological, functional and molecular characterizationL Daya-Grosjean, B Azzarone, R Maunoury, et al.
International Immunology|October 31, 1998
IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblastsC Doucet, D Brouty-Boyé, C Pottin-Clemenceau, et al.
International Journal of Cancer|October 1, 1998
Interleukin (IL)-15 induces survival and proliferation of the growth factor-dependent acute myeloid leukemia M-07e through the IL-2 receptor beta/gammaR Meazza, S Basso, A Gaggero, et al.
European Journal of Immunology|May 1, 1997
Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptidesR Meazza, A Gaggero, F Neglia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1985
A target structure for a series of human cloned natural killer cell lines is recognized by both anti-TNKtar and 4F2 monoclonal antibodiesP Moingeon, A Nowill, G Courtois, et al.
European Journal of Immunology|May 6, 1999
Differential intracellular trafficking, secretion and endosomal localization of two IL-15 isoformsA Gaggero, B Azzarone, C Andrei, et al.
International Journal of Cancer|June 4, 1998
Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissuesD Brouty-Boyé, C Doucet, D Clay, et al.
Cancer Research|April 20, 2001
Tumor cells regulate the lytic activity of tumor-specific cytotoxic t lymphocytes by modulating the inhibitory natural killer receptor functionA Gati, N Guerra, J Giron-Michel, et al.
Pageof 7